Medium materiality6/10
Pelthos Therapeutics price target lowered to $45 from $75 at Alliance Global
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Alliance Global cut Pelthos Therapeutics' target to $45 from $75; current price is $29.07. The target remains above the current price, though the price has changed by -1.55 since the signal.
- Target above price; price down 1.55 since signal.
Key facts
- 01
Target: $45
- 02
Posted price: $29.07
- 03
Analyst firm: Industrial Alliance Securities
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.